Lpl Financial LLC Cure Vac N.V. Transaction History

Lpl Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.73 - $35.25 $132,069 - $316,051	-8,966 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$33.72 - $48.22 $302,333 - $432,340	8,966 New	8,966 $308,000
Q3 2021 Nov 15, 2021	SELL	$49.26 - $74.5 $185,069 - $279,896	-3,757 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$56.91 - $127.53 $34,146 - $76,518	600 Added 19.01%	3,757 $276,000
Q1 2021 May 14, 2021	BUY	$79.79 - $126.29 $251,897 - $398,697	3,157 New	3,157 $289,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $722M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.